Thermo Fisher Scientific is a global leader in allergy and autoimmunity diagnostics, providing you with accurate and clinically relevant testing solutions to aid in disease diagnosis and patient management.
As the gold standard in in-vitro allergy diagnostics, ImmunoCAP solutions provide results that help in optimizing your diagnosis.1
Evidence-based symptom management
ImmunoCAP tests help laboratories provide relevant and science-based information that healthcare providers can use to develop evidence-based symptom-management plans.
High specificity & high sensitivity2-5
Comprising an ever-growing portfolio of more than 50 clinically relevant tests for autoimmune diseases, the EliA portfolio combines high specificity with high sensitivity.
Our customer service team’s ongoing support offers laboratories the necessary confidence to provide a clinically relevant and accurate autoimmunity diagnostic service.
Instruments for today and tomorrow
Flexible and scalable
Designed to optimize workflow efficiency for any sized laboratory and the test volume it may experience, Phadia instruments adapt to your specific needs and scale seamlessly as your laboratory operation grows.
Along with practice parameters and guidelines for clinicians, Thermo Fisher Scientific provides clinical and laboratory training and support, including enhanced clinical insights beyond results.
Phadia AB, owned by Thermo Fisher Scientific, has provided continuous diagnostic innovations for more than five decades.